Literature DB >> 565339

Interaction of Chlamydia psittaci with mouse peritoneal macrophages.

P B Wyrick, E A Brownridge, B E Ivins.   

Abstract

L-cell-grown Chlamydia psittaci elementary bodies (EB) were rapidly phagocytized by mouse peritoneal macrophages in vitro. However, the intracellular fate of chlamydiae in macrophages appeared to be dependent on the multiplicity of infection (MOI), i.e., the EB-to-macrophage ratio, and the treatment of the EB. At an MOI of 1:1 or less, survival is maximal, and growth and multiplication of live, untreated chlamydiae did occur. In contrast, at a high MOI (100:1), survival of chlamydiae is reduced, as confirmed by release of 3H-labeled nucleic acid into the supernatant. At the high MOI, macrophage damage occurred that resulted in significant release of the lactic dehydrogenase, beginning 2 h postinfection. This immediated macrophage cytotoxicity as abolished by pretreatment of EB with heat (5 min at 56 degrees C) and was reduced about 50% by coating EB with homologous antibody. Pretreatment of the chlamydia with heat or opsonizing antibody provides increased uptake of EB by macrophages but may contribute to increased destruction of these obligate intracellular pathogens in professional phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565339      PMCID: PMC422296          DOI: 10.1128/iai.19.3.1061-1067.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  PURIFICATION AND CHEMICAL COMPOSITION OF MENINGOPNEUMONITIS VIRUS.

Authors:  A TAMURA; N HIGASHI
Journal:  Virology       Date:  1963-08       Impact factor: 3.616

2.  Utilization of exogenous thymidine by Chlamydia psittaci growing in the thymidine kinase-containing and thymidine kinase-deficient L cells.

Authors:  T P Hatch
Journal:  J Bacteriol       Date:  1976-02       Impact factor: 3.490

3.  Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjuctivae by eye secretions from humans with trachoma.

Authors:  R L Nichols; R E Oertley; E C Fraser; A B MacDonald; D E McComb
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

4.  Growth of Chlamydia psittaci in macrophages.

Authors:  P B Wyrick; E A Brownridge
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

5.  Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells).

Authors:  G I Byrne
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

6.  Mechanisms of immunity in typhus infections. V. Demonstration of Rickettsia mooseri-specific antibodies in convalescent mouse and human serum cytophilic for mouse peritoneal macrophages.

Authors:  L Beaman; C L Wisseman
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

7.  Mechanisms of immunity in typhus infections. VI. Differential opsonizing and neutralizing action of human typhus rickettsia-specific cytophilic antibodies in cultures of human macrophages.

Authors:  L Beaman; C L Wisseman
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells).

Authors:  J W Moulder; T P Hatch; G I Byrne; K R Kellogg
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Immunity to chlamydial infections of the eye. V. Passive transfer of antitrachoma antibodies to owl monkeys.

Authors:  N S Orenstein; J D Mull; S E Thompson
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

10.  5'-Nucleotidase activity of mouse peritoneal macrophages. I. Synthesis and degradation in resident and inflammatory populations.

Authors:  P J Edelson; Z A Cohn
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

View more
  37 in total

Review 1.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

2.  Characterization of host cell death induced by Chlamydia trachomatis.

Authors:  Songmin Ying; Silke F Fischer; Matthew Pettengill; Debye Conte; Stefan A Paschen; David M Ojcius; Georg Häcker
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

3.  An α-helical core encodes the dual functions of the chlamydial protein IncA.

Authors:  Erik Ronzone; Jordan Wesolowski; Laura D Bauler; Anshul Bhardwaj; Ted Hackstadt; Fabienne Paumet
Journal:  J Biol Chem       Date:  2014-10-16       Impact factor: 5.157

4.  Degradation of Chlamydia trachomatis in human polymorphonuclear leukocytes: an ultrastructural study of peroxidase-positive phagolysosomes.

Authors:  E C Yong; E Y Chi; W J Chen; C C Kuo
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

5.  Interaction of Chlamydia psittaci reticulate bodies with mouse peritoneal macrophages.

Authors:  E Brownridge; P B Wyrick
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

6.  Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis).

Authors:  D M Williams; J Schachter; M H Weiner; B Grubbs
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

7.  Binding, ingestion, and multiplication of Chlamydia trachomatis (L2 serovar) in human leukocyte cell lines.

Authors:  J A Bard; D Levitt
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Cytotoxic cells induced after Chlamydia psittaci infection in mice.

Authors:  J K Lammert
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Nonoxidative antimicrobial effects of human polymorphonuclear leukocyte granule proteins on Chlamydia spp. in vitro.

Authors:  K B Register; C H Davis; P B Wyrick; W M Shafer; J K Spitznagel
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

10.  Isolation and characterization of macrophage phagosomes containing infectious and heat-inactivated Chlamydia psittaci: two phagosomes with different intracellular behaviors.

Authors:  S L Zeichner
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.